Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (Q24245648)

Europe PubMed Central

title

Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (English)

0 references

0 references

1

0 references

Glyn Lewis

9

0 references

Rachel Churchill

5

0 references

Matthew Hotopf

2

Matthew Hotopf

0 references

Rebecca Hardy

8

Rebecca Hardy

0 references

Martin Eccles

6

Martin Eccles

0 references

John R. Geddes

7

John Geddes

0 references

author name string

Nick Freemantle

3

0 references

J Boynton

4

0 references

James Mason

Cochrane Database of Systematic Reviews

10

0 references

publication date

19 July 2006

0 references

published in

0 references

cites work

Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Comparative effects of fluoxetine and amitriptyline on cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Antidepressant use over time in a rural older adult population: the MoVIES Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

The risk-benefit assessment of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Orthostatic side effects of clomipramine and citalopram during treatment for depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A study comparing paroxetine placebo and imipramine in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs. tricyclics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Comparison of fluoxetine and desipramine in depressed outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Does placebo help establish equivalence in trials of new antidepressants?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Antidepressant agents: from tricyclics to serotonin uptake inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. South Wales Antidepressant Drug Trial Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparison of fluoxetine and amitriptyline in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Citalopram versus mianserin. A controlled, double-blind trial in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Paroxetine and amitriptyline in the treatment of depression in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Inadequate dosaging in general practice of tricyclic vs. other antidepressants for depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Recognition and management of depression in general practice: consensus statement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

The compliance with antidepressants in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparison of the antidepressant action of citalopram and amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A comparative trial of a new antidepressant, fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Are SSRIs a cost-effective alternative to tricyclics?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021

The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002791.PUB2

7 January 2021